AR062100A1 - Compuestos y composiciones como moduladores de la senda de hedgehog - Google Patents
Compuestos y composiciones como moduladores de la senda de hedgehogInfo
- Publication number
- AR062100A1 AR062100A1 ARP070103302A ARP070103302A AR062100A1 AR 062100 A1 AR062100 A1 AR 062100A1 AR P070103302 A ARP070103302 A AR P070103302A AR P070103302 A ARP070103302 A AR P070103302A AR 062100 A1 AR062100 A1 AR 062100A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- halogen
- substituted
- alkoxy
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Proporciona un método para modular la actividad de la senda de senalizacion de Hedgehog. En particular, un método para inhibir los estados de crecimiento aberrante resultantes de los fenotipos tales como pérdida de funcion de Ptc, ganancia de funcion de Hedgehog, ganancia de funcion de Smoothened, o ganancia de funcion de Gli, el cual comprende poner en contacto una célula con una cantidad suficiente de un compuesto de formula 1. Reivindicacion 1: Un compuesto de la formula 1 en donde: n se selecciona a partir de 0, 1, y 2; Y1 se selecciona a partir de un enlace y C(O); Y2 se selecciona a partir de un enlace, C(O) y S(O)2; R1 se selecciona a partir de hidrogeno, halogeno, ciano, alquilo C1-2, y alquilo C1-2 sustituido por halogeno; R2 se selecciona a partir de hidrogeno, halogeno, ciano, alquilo C1-3, alcoxilo C1-3, alquilo C1-3 sustituido por halogeno, alcoxilo C1-3 sustituido por halogeno, arilo C6-10-alquilo C0-4, heteroarilo C1-10-alquilo C0-4, cicloalquilo C3-12- alquilo C0-4, hetero-cicloalquilo C3-8-alquilo C0-4, y fenoxilo; en donde este arilo, heteroarilo, cicloalquilo, heterocicloalquilo, o fenoxilo de R2 puede estar opcionalmente sustituido con 1 a 3 radicales independientemente seleccionados a partir de alquilo C1-6, alquilo C1-6 sustituido por halogeno, alcoxilo C1-6, alcoxilo C1-6 sustituido por halogeno, arilo C6-10-alquilo C0-4, heteroarilo C1-10-alquilo C0-4, cicloalquilo C3-12, y hetero-cicloalquilo C3-8, en donde el sustituyente de aril- alquilo de R2 está opcionalmente sustituido con 1 a 3 radicales independientemente seleccionados a partir de halogeno, alquilo C1-6, alquilo C1-6 sustituido por halogeno, alcoxilo C1-6, alcoxilo C1-6 sustituido por halogeno, y metil-piperazinilo; R3 se selecciona a partir de H, halogeno, ciano, alquilo C1-2, alcoxilo C1-3, y alquilo C1-2 sustituido por halogeno; R4 se selecciona a partir de H, halogeno, ciano, alquilo C1-2, alcoxilo C1-3, y alquilo C1-2 sustituido por halogeno; R5 se selecciona a partir de H y alquilo C1-3; L es un radical divalente seleccionado a partir de los grupos de formulas (2) en donde los asteriscos indican el punto de union entre Y2 y R2; en donde cualquier radical divalente de L puede estar adicionalmente sustituido con 1 a 3 radicales independientemente seleccionados a partir de halogeno, hidroxilo, ciano, alquilo C1-4, alquilo C1-4-carbonilamino, alcoxilo C1-4, alcoxilo C1-4-carbonilo, alquilo C1-4 sustituido por halogeno, alquilo C1-3-sulfonilo, alquilo C1-3-sulfonil-amino, alquilo C1-4 sustituido por ciano, y alcoxilo C1-4 sustituido por halogeno; y las sales farmacéuticamente aceptables del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83331806P | 2006-07-25 | 2006-07-25 | |
| US94265007P | 2007-06-07 | 2007-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062100A1 true AR062100A1 (es) | 2008-10-15 |
Family
ID=38962752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103302A AR062100A1 (es) | 2006-07-25 | 2007-07-25 | Compuestos y composiciones como moduladores de la senda de hedgehog |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7928133B2 (es) |
| EP (1) | EP2044065A2 (es) |
| JP (1) | JP2009544730A (es) |
| KR (1) | KR20090031789A (es) |
| AR (1) | AR062100A1 (es) |
| AU (1) | AU2007276788A1 (es) |
| BR (1) | BRPI0714663A2 (es) |
| CA (1) | CA2658782A1 (es) |
| CL (1) | CL2007002175A1 (es) |
| MX (1) | MX2009000947A (es) |
| PE (1) | PE20080948A1 (es) |
| RU (1) | RU2423354C2 (es) |
| TW (1) | TW200817393A (es) |
| WO (1) | WO2008014291A2 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA93548C2 (uk) | 2006-05-05 | 2011-02-25 | Айерем Елелсі | Сполуки та композиції як модулятори хеджхогівського сигнального шляху |
| WO2008039200A1 (en) * | 2006-09-27 | 2008-04-03 | Irm Llc | Methods and compositions for treating lymphoma and myeloma |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| JP5373777B2 (ja) * | 2007-06-07 | 2013-12-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | ヘッジホッグ経路モジュレーターとしてのビフェニルカルボキサミド誘導体 |
| WO2009030952A2 (en) * | 2007-09-05 | 2009-03-12 | Astrazeneca Ab | Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| DK2959900T3 (en) | 2008-06-16 | 2017-06-26 | Univ Tennessee Res Found | CONNECTION TO TREATMENT OF CANCER |
| US8063043B2 (en) * | 2008-09-17 | 2011-11-22 | Novartis Ag | Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide |
| BRPI0920533A2 (pt) | 2008-10-01 | 2020-12-15 | Novartis Ag | Antagonismo de estabilizado para o tratamento de distúrbios relacionados à trilha de porco-espinho |
| AU2010257802A1 (en) * | 2009-06-11 | 2012-01-12 | Siena Biotech S.P.A. | Hedgehog pathway antagonists and therapeutic applications thereof |
| KR20120099155A (ko) | 2010-01-07 | 2012-09-06 | 셀렉사겐 세라퓨틱스 인크. | 헤지호그 저해제 |
| EP3064204A1 (en) | 2010-03-01 | 2016-09-07 | GTx, Inc. | Compounds for treatment of cancer |
| FR2967498B1 (fr) | 2010-11-16 | 2015-01-02 | Centre Nat Rech Scient | Utilisation de derives de quinolinone comme outil de recherche |
| JP5998152B2 (ja) * | 2011-01-25 | 2016-09-28 | ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン | Ｂｃｌ−２／ｂｃｌ−ｘｌ阻害剤およびそれを使用する治療方法 |
| US20120207840A1 (en) * | 2011-02-10 | 2012-08-16 | Aura Biosciences, Inc. | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer |
| EP2653464B1 (en) * | 2012-04-20 | 2017-09-27 | Rohm and Haas Company | Benzylamine hydrophobe |
| CN106905297A (zh) * | 2012-06-15 | 2017-06-30 | 加利福尼亚大学董事会 | 用于脑癌的新颖治疗剂 |
| CN103570625A (zh) * | 2012-07-19 | 2014-02-12 | 南京英派药业有限公司 | N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用 |
| EP3015459A1 (en) * | 2014-10-30 | 2016-05-04 | Sanofi | Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof |
| US10227333B2 (en) | 2015-02-11 | 2019-03-12 | Curtana Pharmaceuticals, Inc. | Inhibition of OLIG2 activity |
| CN107530304A (zh) | 2015-02-27 | 2018-01-02 | 科泰纳制药公司 | Olig2活性的抑制 |
| JP6796638B2 (ja) | 2015-06-04 | 2020-12-09 | ペレファーム, インク.Pellepharm, Inc. | ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用 |
| CN114502540A (zh) | 2019-05-31 | 2022-05-13 | 医肯纳肿瘤学公司 | Tead抑制剂和其用途 |
| CR20220316A (es) | 2019-12-06 | 2022-10-07 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio |
| CN117794920A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL149872A0 (en) * | 1999-12-16 | 2002-11-10 | Schering Corp | Substituted imidazole neuropeptide y y5 receptor antagonists |
| WO2004091610A1 (en) * | 2003-04-10 | 2004-10-28 | Avanir Pharmaceuticals | Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| EP1748989A2 (en) * | 2004-05-12 | 2007-02-07 | ChemoCentryx Inc | Aryl sulfonamides |
| AU2005302279A1 (en) * | 2004-10-28 | 2006-05-11 | Irm Llc | Compounds and compositions as hedgehog pathway modulators |
-
2007
- 2007-07-23 PE PE2007000953A patent/PE20080948A1/es not_active Application Discontinuation
- 2007-07-24 JP JP2009521969A patent/JP2009544730A/ja active Pending
- 2007-07-24 WO PCT/US2007/074268 patent/WO2008014291A2/en active Search and Examination
- 2007-07-24 US US12/374,739 patent/US7928133B2/en not_active Expired - Fee Related
- 2007-07-24 BR BRPI0714663-9A patent/BRPI0714663A2/pt not_active IP Right Cessation
- 2007-07-24 RU RU2009106167/04A patent/RU2423354C2/ru not_active IP Right Cessation
- 2007-07-24 KR KR1020097003730A patent/KR20090031789A/ko active IP Right Grant
- 2007-07-24 AU AU2007276788A patent/AU2007276788A1/en not_active Abandoned
- 2007-07-24 CA CA002658782A patent/CA2658782A1/en not_active Abandoned
- 2007-07-24 EP EP07840497A patent/EP2044065A2/en not_active Withdrawn
- 2007-07-24 MX MX2009000947A patent/MX2009000947A/es not_active Application Discontinuation
- 2007-07-25 AR ARP070103302A patent/AR062100A1/es unknown
- 2007-07-25 CL CL200702175A patent/CL2007002175A1/es unknown
- 2007-07-25 TW TW096127107A patent/TW200817393A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7928133B2 (en) | 2011-04-19 |
| PE20080948A1 (es) | 2008-09-10 |
| WO2008014291A3 (en) | 2008-04-03 |
| BRPI0714663A2 (pt) | 2013-05-07 |
| RU2423354C2 (ru) | 2011-07-10 |
| US20090312308A1 (en) | 2009-12-17 |
| WO2008014291A2 (en) | 2008-01-31 |
| TW200817393A (en) | 2008-04-16 |
| MX2009000947A (es) | 2009-02-05 |
| RU2009106167A (ru) | 2010-08-27 |
| JP2009544730A (ja) | 2009-12-17 |
| CL2007002175A1 (es) | 2008-06-13 |
| AU2007276788A1 (en) | 2008-01-31 |
| KR20090031789A (ko) | 2009-03-27 |
| CA2658782A1 (en) | 2008-01-31 |
| EP2044065A2 (en) | 2009-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062100A1 (es) | Compuestos y composiciones como moduladores de la senda de hedgehog | |
| AR060858A1 (es) | Compuestos y composiciones como moduladores de la senda de hedgehog | |
| AR066492A1 (es) | Derivados de imidazoquinolina, proceso para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de enfermedades virales, bacterianas, alergicas y distintos tipos de canceres. | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| NO20092415L (no) | Heteromonocyklisk forbindelse og anvendelse derav | |
| HRP20080113T3 (en) | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto | |
| EA201070607A1 (ru) | Гербицидные соединения | |
| ATE476431T1 (de) | Piperidin- und azetidinderivate als glyt1- inhibitoren | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR078408A1 (es) | Derivados de indol como moduladores de los crac | |
| NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
| AR061737A1 (es) | Compuestos derivados de pirimidina, un peoceso para su preparacion y composiciones farmaceuticas que los contienen | |
| CO6270288A2 (es) | Composicion fungicida que comprende cantidades significativamente efectivas de un derivadio de amida de acido carboxilico o su sal | |
| NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
| EA201200826A1 (ru) | Инсектицидные соединения, основанные на производных изоксазолина | |
| NO20080391L (no) | Pyrazolbaserte LXR modulatorer | |
| AR060489A1 (es) | Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol | |
| NO20062370L (no) | Amidderivater | |
| DK1753723T3 (da) | Substituerede quinolinderivater som mitotiske kinesininhibitorer | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| RS54595B1 (en) | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives | |
| NO20063865L (no) | Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
| WO2008096769A1 (ja) | 置換されたセルコスポラミド誘導体を含有する医薬 | |
| AR064424A1 (es) | Derivados sustituidos de 1-oxo-ftalazinas y 1-oxo-pirido-piridazinas,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar enfermedades inflamatorias y alergicas del tracto respiratorio. | |
| WO2007020411A8 (en) | Amide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |